BioSpace News Archive

Apnimed, a clinical-stage pharmaceutical company focused on developing oral medicines to treat Obstructive Sleep Apnea and related disorders, announced that the Company’s management team will participate in the Ladenburg Thalmann Virtual Healthcare Conference, held July 13-14, 2021.

Cybin Inc. today announced that it has entered into an exclusive research and development collaboration agreement (the “ Collaboration Agreement ”) with TMS NeuroHealth Centers Inc., a wholly-owned subsidiary of Greenbrook TMS Inc.

Braxia Scientific Corp. is pleased to announce its participation at the upcoming PSYCH Investor Summit: Research & Development conference on July 7, 2021.

The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, has appointed Marco Argenti, co-chief information officer of Goldman Sachs, and Karyn Temple, senior executive vice president and global general counsel for the Motion Picture Association to its board of directors.

There are possibilities that an athlete might suffer detachment of a ligament or tendon and/or any other soft tissue in the body while practicing or during the game.

Development of assays that feature as rapid medical diagnostics attracts groundswell of interest of healthcare systems worldwide.

Catalyst Biosciences, Inc. announced four poster presentations on marzaptacog alfa and dalcinanonog alfa at the upcoming International Society on Thrombosis and Haemostatis Virtual Congress being held from July 17-21, 2021.

Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today announced the appointment of Dr. Preethi Sundaram as Chief Product Development Officer.

Noblegen Inc., an advanced digital biology company, is excited to announce that Craig Cogut, the Founder, Chairman, and CEO of Pegasus Capital Advisors, and Dr. Rajiv Shah, the President of the Rockefeller Foundation, have joined its Board of Directors.

Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced that it will present new preclinical data at the European Crohn’s and Colitis Organisation (ECCO) 2021 Virtual Congress on July 9, 2021.